These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9442416)

  • 1. Does natural erectile function improve following intracavernous injections of vasoactive drugs?
    Sharlip ID
    Int J Impot Res; 1997 Dec; 9(4):193-6. PubMed ID: 9442416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial.
    Montorsi F; Guazzoni G; Strambi LF; Da Pozzo LF; Nava L; Barbieri L; Rigatti P; Pizzini G; Miani A
    J Urol; 1997 Oct; 158(4):1408-10. PubMed ID: 9302132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short term use of intracavernous vasoactive drugs in the treatment of persistent psychogenic erectile dysfunction.
    Ghanem H; Sherif T; Adbel-Gawad T; Asaad T
    Int J Impot Res; 1998 Dec; 10(4):211-4. PubMed ID: 9884916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracavernous injection of prostaglandin E1 in impotent men.
    Stackl W; Hasun R; Marberger M
    J Urol; 1988 Jul; 140(1):66-8. PubMed ID: 3379700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure.
    Virag R; Frydman D; Legman M; Virag H
    Angiology; 1984 Feb; 35(2):79-87. PubMed ID: 6696289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intracavernous injections of vasoactive drugs. Contribution to the study of their value in erectile impotence].
    Bondil P; Dorémieux J; Nguyen Qui JL
    J Urol (Paris); 1987; 93(6):361-8. PubMed ID: 3323319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The interest of early rehabilitation with intracavernous injections following complete prostatectomy].
    Amar E
    Presse Med; 2005 Jul; 34(13 Suppl):15-8. PubMed ID: 16158024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].
    Staerman F; Veilhan LA; Guiraud P; Coeurdacier P; Cipolla B; Lobel B
    Prog Urol; 1996; 6(4):564-8. PubMed ID: 8924934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates.
    Polito M; d'Anzeo G; Conti A; Muzzonigro G
    BJU Int; 2012 Dec; 110(11 Pt C):E954-7. PubMed ID: 23078100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
    Sidi AA; Cameron JS; Duffy LM; Lange PH
    J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of PGE1 in the treatment of erectile deficiency].
    Arena F; Peracchia G; Di Stefano C; Cortellini P
    Acta Biomed Ateneo Parmense; 1996; 67(1-2):49-53. PubMed ID: 10021734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral tadalafil administration plus low dose vasodilator injection: a novel approach to erection induction for penile color duplex ultrasound.
    Yang Y; Hu JL; Ma Y; Wang HX; Chen Z; Xia JG; Wang YX; Huang YR; Chen B
    J Urol; 2011 Jul; 186(1):228-32. PubMed ID: 21575959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction.
    Porst H
    Int J Impot Res; 1997 Dec; 9(4):187-92. PubMed ID: 9442415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does prostaglandin El (PGE1) help restoration of spontaneous erections?].
    Thiounn N; Flam T; Zerbib M; Debré B
    J Urol (Paris); 1993; 99(3):136-8. PubMed ID: 7745271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.
    Martínez-Piñeiro L; Cortés R; Cuervo E; López-Tello J; Cisneros J; Martínez-Piñeiro JA
    Eur Urol; 1998 Oct; 34(4):350-4. PubMed ID: 9748684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.